Delun Luo
Overview
Explore the profile of Delun Luo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
294
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang X, Deng Z, Xu X, Zhu J, Huang Z, Ye Y, et al.
Cell Prolif
. 2025 Feb;
:e13820.
PMID: 39980149
Retinal ischaemia/reperfusion injury (RI/RI) is the primary pathophysiological mechanism underlying retinal ischaemic diseases, potentially resulting in significant and irreversible visual impairment. Currently, there are no effective treatments available for RI/RI,...
2.
Xu X, Fu Y, Luo D, Zhang L, Huang X, Chen Y, et al.
Cell Prolif
. 2024 Aug;
57(11):e13695.
PMID: 39086110
Retinal ischemia/reperfusion injury (RI/R) is a common pathological process in ophthalmic diseases, which can cause severe visual impairment. The mechanisms underlying RI/R damage and repair are still unclear. Scholars are...
3.
Wu Q, Zhu J, Zhang X, Xu X, Luo D, Lin Y, et al.
Cell Prolif
. 2024 Apr;
57(8):e13635.
PMID: 38594962
Age-related macular degeneration (AMD) and diabetic retinopathy (DR) are the world's leading causes of blindness. The retinal pigment epithelium (RPE) and vascular endothelial cell exposed to oxidative stress is the...
4.
Liu T, Huang J, Luo D, Ren L, Ning L, Huang J, et al.
Int J Biol Macromol
. 2024 Mar;
264(Pt 2):130638.
PMID: 38460652
The rational modification of siRNA molecules is crucial for ensuring their drug-like properties. Machine learning-based prediction of chemically modified siRNA (cm-siRNA) efficiency can significantly optimize the design process of siRNA...
5.
Liu X, Xu X, Lai Y, Zhou X, Chen L, Wang Q, et al.
Cell Prolif
. 2024 Mar;
57(7):e13623.
PMID: 38433462
The objective of this study was to investigate the effects and molecular mechanisms of tetrahedral framework nucleic acids-microRNA22 (tFNAs-miR22) on inhibiting pathological retinal neovascularization (RNV) and restoring physiological retinal vessels....
6.
Zhou X, Lai Y, Xu X, Wang Q, Sun L, Chen L, et al.
Cell Prolif
. 2023 Jan;
56(7):e13407.
PMID: 36694349
This study aimed to explore the effect and the molecular mechanism of tetrahedral framework nucleic acids (tFNAs), a novel self-assembled nanomaterial with excellent biocompatibility and superior endocytosis ability, in inhibition...
7.
Lin Y, Li Q, Wang L, Guo Q, Liu S, Zhu S, et al.
Int J Oral Sci
. 2022 Nov;
14(1):51.
PMID: 36316311
With the emergence of DNA nanotechnology in the 1980s, self-assembled DNA nanostructures have attracted considerable attention worldwide due to their inherent biocompatibility, unsurpassed programmability, and versatile functions. Especially promising nanostructures...
8.
Zhang Z, Tang Q, Wang Q, Nie F, Sun L, Luo D, et al.
Interdiscip Sci
. 2021 Nov;
14(2):385-393.
PMID: 34846641
Ophthalmic diseases are disorders that affect the eyes. Hundreds of causal genes and biological pathways have been reported to be closely correlated with ophthalmic diseases. However, these information are scattered...
9.
Kang J, Yu S, Lu S, Xu G, Zhu J, Yan N, et al.
Signal Transduct Target Ther
. 2020 Apr;
5(1):2.
PMID: 32296019
No abstract available.
10.
Zhang Y, He B, Liu K, Ning L, Luo D, Xu K, et al.
Signal Transduct Target Ther
. 2017 Dec;
2:17010.
PMID: 29263914
Vascular endothelial growth factor (VEGF), one of the most important angiogenic factors, plays an essential role in both physiological and pathological angiogenesis through binding to VEGF receptors (VEGFRs). Here we...